Population and Data Sources This study is part of a larger study evaluating the measurement properties of a single item for overall side effect bother, the GP5 item. GP5 is described in more detail below (see Measures). For this study, we accessed commercial clinical cancer trial data from the Vivli data sharing platform. All trials in our study had received HREC/IRB approval.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with John
Contact John, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack